Neurotechnology for Stroke Recovery: Systemic Barriers and Structural Gaps in Rehabilitation Access

Indigenous healing traditions emphasize neuroplasticity as a communal and spiritual process, not merely a biological one. Practices like drumming, storytelling, and collective care are used to 'rewire' the brain through emotional and social reintegration, contrasting with the techno-solutionist approach. However, these methods are systematically excluded from mainstream stroke recovery narratives, which prioritize Western biomedical interventions. The absence of Indigenous knowledge in neurotechnology discourse reflects a broader pattern of epistemic injustice in healthcare.

The history of stroke rehabilitation reveals a pattern of technological hype cycles, from early electrotherapy in the 19th century to today’s brain-computer interfaces. Each era’s 'breakthrough' solution has been marketed as revolutionary, yet systemic barriers—such as lack of insurance coverage for long-term therapy—remain unaddressed. The 1970s saw the rise of constraint-induced movement therapy, which, like today’s implants, promised miraculous recoveries but was inaccessible to most patients. This historical amnesia allows the cycle of hype to repeat without structural change.

Cross-culturally, stroke recovery is framed differently: in Japan, *kaizen* (continuous improvement) principles are applied to rehabilitation, emphasizing incremental progress over time. In West African traditions, herbal remedies and community rituals are often integrated with physical therapy, reflecting a holistic view of healing. These models contrast with the Western focus on discrete, high-tech interventions, suggesting that culturally adapted approaches could improve outcomes. However, such alternatives are rarely considered in neurotechnology development.

Scientific evidence supports neuroplasticity as a key mechanism for stroke recovery, but the efficacy of motorized gloves and implants is still under rigorous study. Studies show that intensive, task-specific therapy—rather than passive technology—drives meaningful neuroplastic changes. Additionally, the long-term effects of brain-computer interfaces on cognitive and emotional health remain poorly understood. The current focus on implants may divert resources from proven therapies like constraint-induced movement therapy and mirror therapy.

Artistic and spiritual traditions offer metaphors for neuroplasticity, such as the Japanese concept of *wabi-sabi* (embracing imperfection) or the African philosophy of *ubuntu* ('I am because we are'). These frameworks reframe stroke recovery as a journey of acceptance and communal support, rather than a battle against disability. Creative therapies, such as music and dance, have been shown to enhance motor recovery by engaging multiple brain regions. Yet, these modalities are sidelined in favor of mechanical solutions.

Future scenarios must account for the scalability of neurotechnology: high costs and specialized training will likely limit access to wealthy nations and urban centers. Climate change may exacerbate stroke risk by increasing heat-related cardiovascular events, particularly in vulnerable populations. Conversely, preventive measures—such as community-based hypertension programs—could reduce stroke incidence by 20-30%. The uncritical adoption of implants without addressing these broader factors risks deepening healthcare inequities.

Marginalized stroke survivors, particularly Black and Indigenous patients in high-income countries, face systemic barriers to rehabilitation, including underfunded public health systems and discriminatory care practices. In the U.S., Black stroke survivors are 30% more likely to experience a second stroke due to untreated hypertension, yet insurance often denies coverage for long-term therapy. Indigenous communities in Canada and Australia report higher stroke mortality rates due to delayed access to culturally competent care. These voices are absent from the narrative, which centers affluent, urban patients.